<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="7351">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03011229</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00077315</org_study_id>
    <nct_id>NCT03011229</nct_id>
  </id_info>
  <brief_title>Endoscopic Ultrasound (EUS) Fine Needle Biopsy (FNB) Submucosal Nodule</brief_title>
  <official_title>Endoscopic Ultrasound Fine Needle Biopsy of Submucosal Lesions of the GI Tract; Finding the Right Needle - A Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the diagnostic accuracy of a novel endoscopic
      ultrasound (EUS) biopsy needle to the current standard EUS needle.

      The investigators hypothesize that with the SharkcoreTM needle a diagnostic yield of 90% is
      possible for subepithelial lesions (SEL) within the Gastrointestinal (GI) tract versus 60%
      yield with the current needle.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2017</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>diagnostic accuracy of biopsy needle</measure>
    <time_frame>end of biopsy, approximately 10 minutes</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>GI Lesions</condition>
  <arm_group>
    <arm_group_label>Pro Core</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject is randomized to ProCore standard needle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medtronic Shark Core</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject is randomized to Medtronic Sharkcore needle</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pro Core Needle</intervention_name>
    <arm_group_label>Pro Core</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>medtronic Sharkcore Needle</intervention_name>
    <arm_group_label>Medtronic Shark Core</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  hypoechoic lesion &gt; 8 mm within the GI lumen

        Exclusion Criteria:

          -  less than 18 years old

          -  Uncorrectable coagulopathy (INR&gt;1.5)

          -  Uncorrectable thrombocytopenia (platelet count &lt;50,000)

          -  Pregnant women

          -  Refusal to consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Jowell</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charlene Carver</last_name>
    <phone>919-668-1681</phone>
  </overall_contact>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>January 17, 2017</lastchanged_date>
  <firstreceived_date>December 28, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
